Partial
Partially Aligned
Patient Risk:
Low
Summary
The once-daily statement and the general statement that Lipitor may be taken with or without food are supported. The label does not specifically address dairy, lactose intolerance, higher-fat dairy, or a requirement to take Lipitor at the same time each day. It also reports measurable food-related decreases in absorption, although LDL-C reduction is similar with or without food.
Category Scores
Accurate Statements
Lipitor is often taken once daily.
The label specifies a dosage range of 10 to 80 mg once daily.
Lipitor can be taken with or without food, without a significant drop in effect.
The label permits administration with or without food and reports similar LDL-C reduction either way. It does not specifically mention dairy-containing meals.
Unsupported Statements
Dairy does not meaningfully reduce Lipitor effectiveness or strongly interfere with its absorption.
The label provides no dairy-specific evidence. It reports that food decreases absorption, while LDL-C reduction is similar with or without food.
A diet change to higher-fat dairy could affect cholesterol levels, but not by reducing Lipitor absorption.
The label advises following an NCEP-recommended diet but does not address higher-fat dairy or establish its effect on cholesterol or Lipitor absorption.
Gastrointestinal upset from lactose intolerance could make it harder to take medications consistently, but it does not reduce Lipitor absorption.
The label advises medication adherence but does not discuss lactose intolerance, gastrointestinal upset, or their effect on atorvastatin absorption.
Lipitor should be taken consistently at the same time each day.
The label says Lipitor may be administered at any time of day and advises adherence, but does not require administration at the same time each day.
Contradictions
Important Omissions
The label reports that food decreases atorvastatin absorption by approximately 25% for Cmax and 9% for AUC, while LDL-C reduction remains similar with or without food.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The once-daily dosing and general with-or-without-food instructions align with the label. The unsupported dairy-specific assurances and same-time instruction are not accompanied by a dosing change, but the response should distinguish label-supported food information from claims the label does not address.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Dairy-specific absorption and effectiveness claims, along with claims about lactose intolerance and higher-fat dairy, are not addressed by the supplied label.
Suggested Improvement
State that the label allows Lipitor with or without food and reports similar LDL-C reduction, while noting the measured food-related absorption changes and that dairy-specific effects and same-time dosing instructions are not specified.